Published in Pflugers Arch on March 07, 2010
Voltage-gated calcium channels. Cold Spring Harb Perspect Biol (2011) 3.36
Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00
Ion channels in innate and adaptive immunity. Annu Rev Immunol (2015) 1.99
Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol (2012) 1.74
Age-related homeostatic midchannel proteolysis of neuronal L-type voltage-gated Ca²⁺ channels. Neuron (2014) 1.68
Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem (2011) 1.37
Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet (2011) 1.37
Dysregulation of Ca(v)1.4 channels disrupts the maturation of photoreceptor synaptic ribbons in congenital stationary night blindness type 2. Channels (Austin) (2013) 1.33
Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol (2012) 1.28
Ca2+-dependent modulation of voltage-gated Ca2+ channels. Biochim Biophys Acta (2011) 1.16
Complex regulation of voltage-dependent activation and inactivation properties of retinal voltage-gated Cav1.4 L-type Ca2+ channels by Ca2+-binding protein 4 (CaBP4). J Biol Chem (2012) 0.97
Ca(v)2 channels mediate low and high voltage-activated calcium currents in Drosophila motoneurons. J Physiol (2011) 0.94
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine. Biochim Biophys Acta (2011) 0.94
The dynamic architecture of photoreceptor ribbon synapses: cytoskeletal, extracellular matrix, and intramembrane proteins. Vis Neurosci (2011) 0.93
Photoreceptor degeneration in two mouse models for congenital stationary night blindness type 2. PLoS One (2014) 0.93
State-dependent signaling by Cav1.2 regulates hair follicle stem cell function. Genes Dev (2013) 0.91
Signaling complexes of voltage-gated calcium channels. Channels (Austin) (2011) 0.87
What can naturally occurring mutations tell us about Ca(v)1.x channel function? Biochim Biophys Acta (2012) 0.87
Orais and STIMs: physiological mechanisms and disease. J Cell Mol Med (2012) 0.87
Biophysics, pathophysiology, and pharmacology of ion channel gating pores. Front Pharmacol (2014) 0.87
Calcineurin Controls Voltage-Dependent-Inactivation (VDI) of the Normal and Timothy Cardiac Channels. Sci Rep (2012) 0.86
C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels. Biophys J (2014) 0.86
Divergent biophysical properties, gating mechanisms, and possible functions of the two skeletal muscle Ca(V)1.1 calcium channel splice variants. J Muscle Res Cell Motil (2011) 0.85
Neutralisation of a single voltage sensor affects gating determinants in all four pore-forming S6 segments of Ca(V)1.2: a cooperative gating model. Pflugers Arch (2012) 0.85
Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease. J Med Chem (2013) 0.84
L-type calcium channels play a critical role in maintaining lens transparency by regulating phosphorylation of aquaporin-0 and myosin light chain and expression of connexins. PLoS One (2013) 0.84
Homeostatic synaptic depression is achieved through a regulated decrease in presynaptic calcium channel abundance. Elife (2015) 0.83
B-cell lymphoma gene regulatory networks: biological consistency among inference methods. Front Genet (2013) 0.83
EF hand-mediated Ca- and cGMP-signaling in photoreceptor synaptic terminals. Front Mol Neurosci (2012) 0.82
Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels. Curr Mol Pharmacol (2015) 0.81
Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG. J Inherit Metab Dis (2013) 0.81
The expression of whirlin and Cav1.3α₁ is mutually independent in photoreceptors. Vision Res (2012) 0.78
Levels of Ca(V)1.2 L-Type Ca(2+) Channels Peak in the First Two Weeks in Rat Hippocampus Whereas Ca(V)1.3 Channels Steadily Increase through Development. J Signal Transduct (2012) 0.78
Emerging evidence for specific neuronal functions of auxiliary calcium channel α₂δ subunits. Gen Physiol Biophys (2014) 0.78
Decreased temporal precision of neuronal signaling as a candidate mechanism of auditory processing disorder. Hear Res (2015) 0.78
A naturally occurring truncated Cav1.2 α1-subunit inhibits Ca2+ current in A7r5 cells. Am J Physiol Cell Physiol (2013) 0.77
Decalmodulation of Cav1 channels by CaBPs. Channels (Austin) (2015) 0.77
Spectrum of Cav1.4 dysfunction in congenital stationary night blindness type 2. Biochim Biophys Acta (2014) 0.77
GDF-15 enhances intracellular Ca2+ by increasing Cav1.3 expression in rat cerebellar granule neurons. Biochem J (2016) 0.75
Measuring Ca2+-Dependent Modulation of Voltage-Gated Ca2+ Channels in HEK-293T Cells. Cold Spring Harb Protoc (2016) 0.75
CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics. Eur Biophys J (2016) 0.75
Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. Curr Mol Pharmacol (2015) 0.75
Channelopathies: summary of the hot topic keynotes session. Neurotoxicology (2011) 0.75
Voltage-gated calcium channels - from basic mechanisms to disease. J Physiol (2016) 0.75
Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. Biophys J (2017) 0.75
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol (2004) 11.39
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell (2004) 7.45
A proton pore in a potassium channel voltage sensor reveals a focused electric field. Nature (2004) 5.66
Calmodulin is the Ca2+ sensor for Ca2+ -dependent inactivation of L-type calcium channels. Neuron (1999) 5.32
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev (2005) 5.25
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03
Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A (2005) 4.14
Gating pore current in an inherited ion channelopathy. Nature (2007) 3.41
Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci (2001) 2.99
Voltage-sensing arginines in a potassium channel permeate and occlude cation-selective pores. Neuron (2005) 2.94
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Voltage sensor conformations in the open and closed states in ROSETTA structural models of K(+) channels. Proc Natl Acad Sci U S A (2006) 2.81
Histidine scanning mutagenesis of basic residues of the S4 segment of the shaker k+ channel. J Gen Physiol (2001) 2.79
Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci (2004) 2.62
Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A (2003) 2.60
Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation. Proc Natl Acad Sci U S A (2002) 2.48
Signaling from synapse to nucleus: the logic behind the mechanisms. Curr Opin Neurobiol (2003) 2.42
FRET two-hybrid mapping reveals function and location of L-type Ca2+ channel CaM preassociation. Neuron (2003) 2.37
Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci (2009) 2.35
Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci (2005) 2.27
Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. Proc Natl Acad Sci U S A (1999) 2.23
The II-III loop of the skeletal muscle dihydropyridine receptor is responsible for the Bi-directional coupling with the ryanodine receptor. J Biol Chem (1999) 2.22
A highly Ca2+-sensitive pool of vesicles contributes to linearity at the rod photoreceptor ribbon synapse. Neuron (2004) 2.14
The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci (2006) 2.10
Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem (2000) 2.09
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet (1997) 1.88
G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. J Neurosci (2005) 1.84
K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci U S A (2009) 1.77
The calcium current in inner segments of rods from the salamander (Ambystoma tigrinum) retina. J Physiol (1984) 1.70
Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. J Clin Invest (2004) 1.69
C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. Nat Neurosci (2006) 1.69
A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc Natl Acad Sci U S A (2005) 1.65
The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution. J Neurosci (2004) 1.57
Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation. J Neurosci (2003) 1.47
Molecular cloning of multiple subtypes of a novel rat brain isoform of the alpha 1 subunit of the voltage-dependent calcium channel. Neuron (1991) 1.45
Neuronal L-type calcium channels open quickly and are inhibited slowly. J Neurosci (2005) 1.43
International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev (2003) 1.40
Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation. Invest Ophthalmol Vis Sci (2006) 1.38
Switching off calcium-dependent inactivation in L-type calcium channels by an autoinhibitory domain. Proc Natl Acad Sci U S A (2006) 1.37
Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J Neurosci (2010) 1.37
Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp Neurol (1999) 1.35
Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem (2008) 1.32
Molecular identity, synaptic localization, and physiology of calcium channels in retinal bipolar cells. J Neurosci Res (2003) 1.29
Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes autosomal recessive cone dystrophy. Am J Hum Genet (2006) 1.29
Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochem Soc Trans (2006) 1.28
Enzyme-inhibitor-like tuning of Ca(2+) channel connectivity with calmodulin. Nature (2010) 1.28
Calcium channels and channelopathies of the central nervous system. Mol Neurobiol (2002) 1.27
Paradoxical depolarization of BA2+- treated muscle exposed to low extracellular K+: insights into resting potential abnormalities in hypokalemic paralysis. Muscle Nerve (2008) 1.26
Association of CaV1.3 L-type calcium channels with Shank. J Neurosci (2005) 1.25
Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin) (2008) 1.25
The molecular architecture of ribbon presynaptic terminals. Mol Neurobiol (2009) 1.24
Functional characterization of the L-type Ca2+ channel Cav1.4alpha1 from mouse retina. Invest Ophthalmol Vis Sci (2004) 1.21
Muscle channelopathies and critical points in functional and genetic studies. J Clin Invest (2005) 1.21
Structural requirements of the dihydropyridine receptor alpha1S II-III loop for skeletal-type excitation-contraction coupling. J Biol Chem (2003) 1.20
The dihydropyridine-sensitive calcium channel subtype in cone photoreceptors. J Gen Physiol (1996) 1.19
Whole-cell and single-channel analysis of P-type calcium currents in cerebellar Purkinje cells of leaner mutant mice. J Neurosci (1998) 1.18
Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels. J Neurosci (2005) 1.18
Erbin enhances voltage-dependent facilitation of Ca(v)1.3 Ca2+ channels through relief of an autoinhibitory domain in the Ca(v)1.3 alpha1 subunit. J Neurosci (2007) 1.17
Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur J Neurosci (2006) 1.15
Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol (1999) 1.14
The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet (2009) 1.12
Critical role for the beta regulatory subunits of Cav channels in T lymphocyte function. Proc Natl Acad Sci U S A (2006) 1.11
Gain of rod to horizontal cell synaptic transfer: relation to glutamate release and a dihydropyridine-sensitive calcium current. J Neurosci (1997) 1.10
Structural determinants of L-type channel activation in segment IIS6 revealed by a retinal disorder. J Biol Chem (2005) 1.10
Calcium-dependent inactivation and depletion of synaptic cleft calcium ions combine to regulate rod calcium currents under physiological conditions. Eur J Neurosci (2002) 1.09
Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F. Can J Ophthalmol (2000) 1.07
The electroretinographic diagnosis of the incomplete form of congenital stationary night blindness. Vision Res (1995) 1.06
L-type calcium channels contribute to the tottering mouse dystonic episodes. Mol Pharmacol (1999) 1.02
Association of whirlin with Cav1.3 (alpha1D) channels in photoreceptors, defining a novel member of the usher protein network. Invest Ophthalmol Vis Sci (2009) 1.01
Calcium channel agonists and dystonia in the mouse. Mov Disord (2000) 1.00
Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse. Neuroscience (1998) 0.99
Roles of Ca(v) channels and AHNAK1 in T cells: the beauty and the beast. Immunol Rev (2009) 0.98
Structural model of the Ca V 1.2 pore. Channels (Austin) (2008) 0.98
L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion. Cell Calcium (2007) 0.96
Cav1.4 encodes a calcium channel with low open probability and unitary conductance. Biophys J (2005) 0.96
Deletion of the L-type calcium channel Ca(V) 1.3 but not Ca(V) 1.2 results in a diminished sAHP in mouse CA1 pyramidal neurons. Hippocampus (2011) 0.94
Defective survival of naive CD8+ T lymphocytes in the absence of the beta3 regulatory subunit of voltage-gated calcium channels. Nat Immunol (2009) 0.93
Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia. Am J Physiol (1992) 0.92
Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes. J Physiol (1995) 0.92
Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression. J Neurochem (2006) 0.92
Functional analysis of congenital stationary night blindness type-2 CACNA1F mutations F742C, G1007R, and R1049W. Neuroscience (2007) 0.92
Architecture and gating of Hv1 proton channels. J Physiol (2009) 0.91
Temperature dependence of Cav1.4 calcium channel gating. Neuroscience (2007) 0.91
Calmodulin is a functional regulator of Cav1.4 L-type Ca2+ channels. J Biol Chem (2009) 0.91
Severe prognosis in a large family with hypokalemic periodic paralysis. Muscle Nerve (2003) 0.89
Altered functional expression of Purkinje cell calcium channels precedes motor dysfunction in tottering mice. Neuroscience (2007) 0.87
The Ca(v)1.4 calcium channel: more than meets the eye. Channels (Austin) (2007) 0.86
Abnormalities of the photoreceptor-bipolar cell synapse in a substrain of C57BL/10 mice. Invest Ophthalmol Vis Sci (2000) 0.86
Molecular dynamics and mutational analysis of a channelopathy mutation in the IIS6 helix of Ca V 1.2. Channels (Austin) (2008) 0.85
Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family. J Hum Genet (2009) 0.82
Using mutant mice to study the role of voltage-gated calcium channels in the retina. Adv Exp Med Biol (2002) 0.81
Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet (2011) 2.69
Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00
Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. J Clin Invest (2004) 1.69
C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. Nat Neurosci (2006) 1.69
Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and microtubule dynamics. J Clin Invest (2011) 1.60
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol (2008) 1.40
Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem (2011) 1.37
Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy. Hum Mutat (2011) 1.36
Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem (2008) 1.32
Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin) (2008) 1.25
Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels. J Neurosci (2005) 1.18
Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem (2001) 1.16
Systemic splicing factor deficiency causes tissue-specific defects: a zebrafish model for retinitis pigmentosa. Hum Mol Genet (2010) 1.13
Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res (2008) 1.13
Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis (2008) 1.05
Deafblindness in French Canadians from Quebec: a predominant founder mutation in the USH1C gene provides the first genetic link with the Acadian population. Genome Biol (2007) 1.04
Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule. Mol Cell Neurosci (2010) 1.01
Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels. Channels (Austin) (2008) 0.99
Usher syndrome type 1 due to missense mutations on both CDH23 alleles: investigation of mRNA splicing. Hum Mutat (2008) 0.96
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3. Orphanet J Rare Dis (2012) 0.96
Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression. J Neurochem (2006) 0.92
L-type Ca2+ channels in Ca2+ channelopathies. Biochem Biophys Res Commun (2004) 0.90
What can naturally occurring mutations tell us about Ca(v)1.x channel function? Biochim Biophys Acta (2012) 0.87
Oestrogen directly inhibits the cardiovascular L-type Ca2+ channel Cav1.2. Biochem Biophys Res Commun (2007) 0.86
Synthesis, characterization, and application of cy-dye- and alexa-dye-labeled hongotoxin(1) analogues. The first high affinity fluorescence probes for voltage-gated K+ channels. Bioconjug Chem (2002) 0.83
Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression. J Neurosci (2014) 0.81
Identification of a novel LCA5 mutation in a Pakistani family with Leber congenital amaurosis and cataracts. Mol Vis (2011) 0.80
Two truncating USH3A mutations, including one novel, in a German family with Usher syndrome. Mol Vis (2007) 0.79
Extended mutation spectrum of Usher syndrome in Finland. Acta Ophthalmol (2012) 0.78
Use-dependent block of voltage-gated Cav2.1 Ca2+ channels by petasins and eudesmol isomers. J Pharmacol Exp Ther (2009) 0.78
A novel VPS13B mutation in two brothers with Cohen syndrome, cutis verticis gyrata and sensorineural deafness. Eur J Hum Genet (2009) 0.75